EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

KIF23 is associated with a poor prognosis, basal subtypes and immunotherapy response in urothelial carcinoma

Naofumi Nomura iD, Yohei Sekino iD, Yoshinori Shigematsu iD, Go Kobayashi iD, Hikaru Nakahara iD, Ryo Tasaka iD, Yuki Kohada iD, Kenshiro Takemoto iD, Miki Naito iD, Shunsuke Miyamoto iD, Kohei Kobatake iD, Hiroyuki Kitano iD und 6 weitere

Investigative and Clinical Urology · 2026 · 67 (6) · 530

DOI: 10.4111/icu.20260097 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Investigative and Clinical Urology, 2026. Verfasst von Naofumi Nomura und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Immunotherapy, Carcinoma, Transitional Cell, Kinesins. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsImmunotherapyCarcinoma, Transitional CellKinesinsHumansPrognosisFemaleMaleBiomarkers, TumorAntibodies, Monoclonal, HumanizedAgedMiddle AgedTreatment OutcomeMicrotubule-Associated Proteins

Stichwörter der Autor:innen

Biomarkers, tumorBladder cancerCarcinoma, transitional cellImmunotherapyKIF23 protein, human

Substanzen

KIF23 protein, humanatezolizumabBiomarkers, TumorAntibodies, Monoclonal, HumanizedKinesinsMicrotubule-Associated Proteins

Autor:innen und Institutionen

  • Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan. akikosekino@gmail.com.
  • Department of Urology, Hiroshima Memorial Hospital, Hiroshima, Japan.
  • Laboratory of Molecular Pathology, Department of Molecular Biosciences, Radiation Effects Research Foundation, Hiroshima, Japan.
  • Department of Clinical and Molecular Genetics, Hiroshima University Hospital, Hiroshima, Japan.

ORCID-Profile: Naofumi Nomura, Yohei Sekino, Yoshinori Shigematsu, Go Kobayashi, Hikaru Nakahara, Ryo Tasaka, Yuki Kohada, Kenshiro Takemoto, Miki Naito, Shunsuke Miyamoto, Kohei Kobatake, Hiroyuki Kitano, Keisuke Goto, Akihiro Goriki, Keisuke Hieda, Hiroaki Niitsu, Takao Hinoi, Nobuyuki Hinata

Zitieren

APA

Nomura, N., Sekino, Y., Shigematsu, Y., Kobayashi, G., Nakahara, H., Tasaka, R., Kohada, Y., Takemoto, K., Naito, M., Miyamoto, S., Kobatake, K., Kitano, H., Goto, K., Goriki, A., Hieda, K., Niitsu, H., Hinoi, T., & Hinata, N. (2026). KIF23 is associated with a poor prognosis, basal subtypes and immunotherapy response in urothelial carcinoma. Investigative and Clinical Urology, 67(6), 530. https://doi.org/10.4111/icu.20260097

Vancouver

Nomura N, Sekino Y, Shigematsu Y, Kobayashi G, Nakahara H, Tasaka R, et al. KIF23 is associated with a poor prognosis, basal subtypes and immunotherapy response in urothelial carcinoma. Investigative and Clinical Urology. 2026;67(6):530. doi:10.4111/icu.20260097

BibTeX
@article{Nomura2026,
  author = {Nomura, Naofumi and Sekino, Yohei and Shigematsu, Yoshinori and Kobayashi, Go and Nakahara, Hikaru and Tasaka, Ryo and Kohada, Yuki and Takemoto, Kenshiro and Naito, Miki and Miyamoto, Shunsuke and Kobatake, Kohei and Kitano, Hiroyuki and Goto, Keisuke and Goriki, Akihiro and Hieda, Keisuke and Niitsu, Hiroaki and Hinoi, Takao and Hinata, Nobuyuki},
  title = {KIF23 is associated with a poor prognosis, basal subtypes and immunotherapy response in urothelial carcinoma},
  journal = {Investigative and Clinical Urology},
  year = {2026},
  volume = {67},
  number = {6},
  pages = {530},
  doi = {10.4111/icu.20260097}
}
Kostenlos starten →